Back
American Vanguard Corp. Vs. Oruka Therapeutics, Inc. Industry Stock Comparison
Sell
24
AVD
American Vanguard Corp.
Last Price:
$3.88
Seasonality Move:
11.41%
Sell
40
ORKA
Oruka Therapeutics, Inc.
Last Price:
$31.98
Seasonality Move:
-10.99%
Sell
24
American Vanguard Corp. (AVD)
is a Sell
Is American Vanguard Corp. a Buy, Sell or Hold?
-
The current American Vanguard Corp. [AVD] share price is $3.88. The Score for AVD is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
-
AVD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Oruka Therapeutics, Inc. (ORKA)
is a Sell
Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Oruka Therapeutics, Inc. [ORKA] share price is $31.97. The Score for ORKA is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
ORKA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AVD Stock Price Chart
What is American Vanguard Corp.'s stock price today?
-
The American Vanguard Corp. share price today is $3.88Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AVD is experiencing slight selling pressure.
ORKA Stock Price Chart
What is Oruka Therapeutics, Inc.'s stock price today?
-
The Oruka Therapeutics, Inc. share price today is $31.97Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ORKA is experiencing slight buying pressure.
AVD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 32.78 | Sell |
| Chaikin Money Flow: | -61473 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.05 - 4.57) | Sell |
| Bollinger Bands (100): | (4.47 - 5.49) | Sell |
ORKA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.74 | Buy |
| Relative Strength Index (14 RSI): | 61.53 | Buy |
| Chaikin Money Flow: | 394649 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (28.23 - 31.09) | Buy |
| Bollinger Bands (100): | (15.89 - 28.91) | Buy |
AVD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.04 | Sell |
| 20-day SMA: | 4.26 | Sell |
| 50-day SMA: | 4.67 | Sell |
| 200-day SMA: | 4.57 | Sell |
| 8-day EMA: | 4.01 | Sell |
| 20-day EMA: | 4.23 | Sell |
| 50-day EMA: | 4.55 | Sell |
| 200-day EMA: | 4.94 | Sell |
ORKA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 29.97 | Buy |
| 20-day SMA: | 30.06 | Buy |
| 50-day SMA: | 28.52 | Buy |
| 200-day SMA: | 16.89 | Buy |
| 8-day EMA: | 30.34 | Buy |
| 20-day EMA: | 29.78 | Buy |
| 50-day EMA: | 27.54 | Buy |
| 200-day EMA: | 21.05 | Buy |
American Vanguard Corp. Earnings Growth & AVD Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and a decrease next year of $0.00 per share.
Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.63 per share, and a decrease next year of $0.32 per share.
American Vanguard Corp. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Oruka Therapeutics, Inc. Technical Analysis
| Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||